Security Snapshot

INTELLIGENT BIO SOLUTIONS INC. - Common Stock, $0.01 par value (INBS) Institutional Ownership

CUSIP: 36151G105

13F Institutional Holders and Ownership History from Q4 2020 to Q1 2023

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
1,637,347
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • INBS - INTELLIGENT BIO SOLUTIONS INC. - Common Stock, $0.01 par value is tracked under CUSIP 36151G105.
  • Latest finished 13F holder period is not available.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 9 to 0 between Q4 2022 and Q1 2023.
  • SEC-reported value moved from $75,136 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

36151G105

Latest holder period

n/a

13F holders

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
INBS
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 10% 163,571 Armistice Capital, LLC 31 Mar 2026

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
10
Latest
n/a
Rows shown
1-10 of 10
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q1 0 $0 -$75,136 0
2022 Q4 375,871 $75,136 +$4,575 $0.20 9
2022 Q3 328,873 $138,000 -$64,176 $0.42 7
2022 Q2 415,093 $272,000 -$94,101 $0.65 12
2022 Q1 533,641 $416,000 +$152,944 $0.78 13
2021 Q4 241,746 $347,000 -$296,989 $1.43 8
2021 Q3 343,799 $867,000 -$2,209,201 $2.52 8
2021 Q2 852,918 $3,361,000 +$3,154,255 $3.94 11
2021 Q1 51,042 $291,000 -$72,158 $5.84 6
2020 Q4 49,211 $365,000 +$365,000 $7.41 4
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .